Autopsy report · NCT04000334

Early Transcranial Doppler Goal Directed Therapy After Cardiac Arrest: a Pilot Study

“Due to the difficulty of recruiting patients and the fact that, despite the team's best efforts, the inclusion period initially planned had largely passed, it did not appear ethical to continue the study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month before it started.
• Ran for about 2 years 11 months before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Centre Hospitalier le Mans

Sponsor type

University, hospital or other

Conditions

Cardiac Arrest; Cerebral Lesion; Ischemic Encephalopathy; Ischemic Reperfusion Injury

Interventions

MAP increased to optimize cerebral blood flow; MAP between 65 and 85 mmHg

Participants

20

Sites

1

Countries

France

Trials that died the same way

• Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
  “The study was stopped because there were not enough eligible patients to complete the study.” (69% match in meaning)
• Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
  “The study stopped because patient enrollment requirements were not met.” (68% match in meaning)
• Assessment of Artificial Intelligence Algorithms for ROTEM
  “The study was stopped because it was considered unlikely that the required number of patients could be prospectively recruited across the participating study centers.” (68% match in meaning)
• Bioavailability of Voriconazole
  “no eligible patients; study stopped without inclusion” (67% match in meaning)
• Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
  “Number of enrolled patients was insufficient during planned inclusion time.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.